Effect of single intravesical instillation of highly concentrated hyaluronic acid and chondroitin sulphate for treatment of lower urinary tract symptoms by ureteral stent indwelling

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001527

Enrollment

Registered

2015-06-18

Start date

2015-06-30

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : measure medicate Iarulil patient(Iarulil, 50ml, once, medicate in bladder when removal urinary catheters) against medicate saline patient(saline, 50ml, once, medicate in bladder when removal ur

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patient with ureteral stent inducing after removal of ureteral stone (2) patient who has ureteral stent indwelling or lithotomy among the urinary stone patient who had pain of collateral

Exclusion criteria

Exclusion criteria: (1) history of urethral stricture or neurogenic bladder (2) history of psychosis or taking medicine of antipsychotic drug (3) who has hypersensitiveness about similar type of drugs (4) who has renal failure or major hepatic insufficiency (5) who has history of urinary tract infection within 1 month (6) who taking medicine of steroid or immunosuppressive drug (7) during pregnancy or be expected to pregnancy (8) who taking antibiotics for prevention

Design outcomes

Primary

Measure	Time frame
Ureteral Stent Symptom Questionnaire (USSQ)	—

Secondary

Measure	Time frame
International Prostate Symptom Score (IPSS);Visual Analogue pain Score (VAS)	—

Countries

Korea, Republic of

Contacts

Public ContactJaeHeon Kim

Soon Chun Hyang University Hospital Seoul

piacekjh@hanmail.net

Outcome results